Immunovant
IMVT
IMVT
147 hedge funds and large institutions have $1.86B invested in Immunovant in 2020 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 54 increasing their positions, 39 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
4.03% less ownership
Funds ownership: 45.23% → 41.2% (-4%)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
147
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$58.7M | |
| 2 | +$40.8M | |
| 3 | +$33.1M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$32.2M |
| 5 |
Goldman Sachs
New York
|
+$30.6M |
Top Sellers
| 1 | -$58M | |
| 2 | -$42.1M | |
| 3 | -$32.1M | |
| 4 |
BI
BVF Inc
San Francisco,
California
|
-$31.6M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$15.4M |